Search
Exact matches only
Search in title
Search in content
Search in excerpt
Search in comments
Filter by Custom Post Type

MYDX

MyDx, Inc.

Bullish (9) 75%
Bearish (3) 25%

Vote by Logging in -or- Becoming a Registered Member

Home Forums MYDX

MYDX Quote
MYDX Wall
MYDX Chat
MYDX Forum
MYDX News

MYDX Quote

Price
0.0041
Change
+0.0000 +0.0000%
Ask
N/A
Bid
N/A
Previous Close
0.0041
Open
0.0041
Volume
4,044,326
Average Vol (30d)
11,333,700
Daily Range
0.0039 - 0.0042
52Wk Range
0.0010 - 0.0850
Dividend
N/A
Net Dividend Yield
N/A

MYDX Latest Activity

MYDX News

MyDx Featured by Canadian Tier 1 Business News Network (BNN), Toronto Life Magazine, and Global News

Published: Tuesday August 29, 2017

SAN DIEGO, Aug. 29, 2017 /PRNewswire/ -- MyDx, Inc. (MYDX), a rapidly growing science and technology company that has developed MyDx®, the first multi-use handheld chemical analyzer for consumers, announced that it was recently featured by Canadian Tier 1 Media Outlets including Business News Network (BNN), Toronto Life Magazine, and Global News. CEO Daniel Yazbeck will also be speaking on a panel at MJAC2017 InvestorsHub International Cannabis Conference entitled "Investing in the Picks and Shovels of the Industry" at 12:00 p.m. Pacific Time on Saturday September 2nd at the JW Marriott Los Angeles.

MyDx Reports Second Quarter Results

Published: Monday August 21, 2017

MyDx sold out of its signature handheld analyzer in Q1 on stronger than expected demand leading to a backlog of orders and customer deposits that are were filled in Q2. The Company expects to continue to receive consistent growing demand for its analyzer based on word of mouth and referrals mainly as well as a new marketing initiatives the company launched late June which is generating new customer awareness and product orders from Canada.

MyDx Files Complaint Against Former Chief Operating Officer, Protects Unique AeroDx Diagnostic Platform and Addresses Toxic Financier's Unauthorized Conversion

Published: Tuesday July 18, 2017

SAN DIEGO, July 18, 2017 /PRNewswire/ -- MyDx, Inc. (MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer initially designed for cannabis professionals and retail consumers to measure the chemicals in cannabis and track their feedback on how each sample is impacting their physiology, today announced that all previously reported variable toxic debts have been satisfied through the unauthorized conversion of the Crown Bridge note and has also filed a lawsuit against its former COO and other defendants who have attempted to create a competitive advantage with its anticipated product launch of its air quality sensor: AeroDx®. On July 14, 2017, the Company and its Chief Executive Officer, Daniel Yazbeck, filed a complaint in Superior Court of California against a series of Defendants who have allegedly engaged in unfair business practices, made false statements about the Company, its products, and Mr. Yazbeck at investor events and on online investor platforms.  There can be no assurance about the results or on the outcome of the lawsuit, however, the company took aggressive steps it felt were necessary to protect its business and its shareholders.

MYDX Chat

Only logged in users are allowed to enter the chat

Join Chat by Logging in -or- Becoming a Registered Member

MYDX Forum

This forum contains 7 topics and 1 reply, and was last updated by  Douglas 5 months, 1 week ago.

Viewing 7 topics - 1 through 7 (of 7 total)
Viewing 7 topics - 1 through 7 (of 7 total)

You must be logged in to create new topics.